Cryptotanshinone Inhibits Bladder Cancer Cell Malignant Progression in a Lipopolysaccharide-Induced Inflammatory Microenvironment through NLRP3 Inhibition
Background. Bladder cancer (BC) is one of the most common malignancies of the urogenital system. This study assessed the nucleotide-binding oligomerization domain and leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) in BC as well as the effects of cryptotanshinone on changes in BC m...
Saved in:
| Main Authors: | Chenye Tang, Xiao Guo, Yu Li, Yongxiang Yi, Zhiling Tang, Qihui Zhang, Bairu Luo, Kean Chen, Ke Liang, Gang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2024/8828367 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome
by: Wei Zhang, et al.
Published: (2025-08-01) -
Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer
by: Qun Wang, et al.
Published: (2025-01-01) -
Clusterin inhibits lipopolysaccharide induced liver injury
by: Hye-Young Seo, et al.
Published: (2025-02-01) -
Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications
by: Zheng Z, et al.
Published: (2024-12-01) -
Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer: Erratum
by: Qun Wang, et al.
Published: (2025-03-01)